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Abstract
We have isolated a cDNA from a rabbit intestinal cDNA library which, when co-expressed with the heavy chain of the
human 4F2 antigen (4F2hc) in mammalian cells, induces system L-like amino acid transport activity. This protein, called
LAT2, consists of 535 amino acids and is distinct from LAT1 which also interacts with 4F2hc to induce system L-like amino
acid transport activity. LAT2 does not interact with rBAT, a protein with a significant structural similarity to 4F2hc. The
4F2hc/LAT2-mediated transport process differs from the 4F2hc/LAT1-mediated transport in substrate specificity, substrate
affinity, tissue distribution, interaction with D-amino acids, and pH-dependence. The 4F2hc/LAT2-associated transport
process has a broad specificity towards neutral amino acids with Kt values in the range of 100^1000 WM, does not interact
with D-amino acids to any significant extent, and is stimulated by acidic pH. In contrast, the 4F2hc/LAT1-associated
transport process has a narrower specificity towards neutral amino acids, but with comparatively higher affinity (Kt values in
the range of 10^20 WM), interacts with some D-amino acids with high affinity, and is not influenced by pH. LAT2 is expressed
primarily in the small intestine and kidney, whereas LAT1 exhibits a much broader tissue distribution. ß 2000 Elsevier
Science B.V. All rights reserved.
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1. Introduction
The digestion products of dietary proteins are ab-
sorbed in the small intestine in the form of small
peptides and free amino acids [1^3]. While the ab-
sorption of peptides is mediated predominantly by a
single peptide transporter (PEPT1), the absorption of
amino acids involves participation of several trans-
port systems. The amino acid transport systems in
the intestine di¡er in their substrate speci¢city and
driving force. In recent years, several amino acid
transporters have been cloned and functionally char-
acterized [4^6]. However, most of these transporters
have been cloned from non-intestinal tissues and
these transporters may or may not be expressed in
the intestine. The amino acid transporters that have
been characterized at the molecular level and are
known to be expressed in the intestine include
ATB0/ASCT2 [7], b0; [5], and y L [8,9]. ATB0 is
a Na-dependent neutral amino acid transporter that
is expressed in the intestine [7] as well as in other
non-intestinal tissues [10]. b0; is a Na-independent
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amino acid transporter that is speci¢c for neutral and
cationic amino acids. It consists of at least two sub-
units, one of which (rBAT) has been cloned and
characterized [5]. Genetic mutations in rBAT are re-
sponsible for a subgroup of patients with cystinuria,
an intestinal and renal disorder associated with de-
fective absorption of cationic and neutral amino
acids and cystine [5,11]. y L is a Na-independent
transporter for cationic amino acids and Na-de-
pendent transporter for neutral amino acids [5,6]. It
also consists of two subunits, one of which is the
heavy chain of the cell surface antigen 4F2 and the
other is y LAT1 [8,9,12]. Genetic mutations in y
LAT1 are responsible for lysinuric protein intoler-
ance, an intestinal and renal disorder associated
with defective absorption of cationic and neutral
amino acids [13,14].
Recently, the amino acid transport system L has
been characterized at the molecular level [15^17].
This is a Na-independent transporter for neutral
amino acids. It also consists of two subunits, one
of which is the heavy chain of the cell surface antigen
4F2 and the other is LAT1. Northern blot analysis
has shown that LAT1 transcripts are not expressed
in the small intestine. With an aim to determine
whether the small intestine expresses any amino
acid transporter that is structurally related to
LAT1, we screened in the present study a rabbit in-
testinal cDNA library with human LAT1 cDNA as a
probe. This screening resulted in the isolation of a
cDNA that interacts with 4F2 heavy chain to induce
a system L-like amino acid transport activity. Even
though this newly identi¢ed transport system exhibits
functional characteristics similar to the 4F2hc/LAT1
complex-induced system L activity, there are signi¢-
cant di¡erences. Accordingly, we refer to this new
transporter subunit as LAT2. Here we describe the
structural features of LAT2 and the functional char-
acteristics of the transport system induced by the
4F2hc/LAT2 complex.
2. Materials and methods
2.1. Isolation and sequence determination of rabbit
LAT2 cDNA
The rabbit intestinal cDNA library [7] was
screened with a 1.7-kbp fragment of human LAT1
cDNA [17] obtained by digestion of the full-length
cDNA with KpnI/PvuII. The probe was labeled with
[K-32P]dCTP by random priming using the Ready-to-
go oligolabeling beads (Amersham Pharmacia Bio-
tech). The screening was done under low stringency
conditions [18^20]. Positive clones were identi¢ed
and the colonies puri¢ed by secondary screening.
The clones were analyzed for restriction sites and
partially sequenced at their 5P ends. This analysis
revealed that the clones isolated from the library
consisted of two di¡erent types of cDNAs. One
was found to be identical to the b0; amino acid
transporter cDNA that was reported recently from
our laboratory [21]. The other represented a new
cDNA that has not been previously described. There
were four positive clones containing this cDNA in-
sert. The size of the insert was, however, di¡erent in
each clone. The clone with the longest cDNA insert
was selected for further analysis. Both sense and
antisense strands of the cDNA were sequenced by
primer walking using Taq DyeDeoxy terminator
cycle sequencing in an automated Perkin-Elmer Ap-
plied Biosystems 377 Prism DNA sequencer. The se-
quence was analyzed using the GCG sequence anal-
ysis software package GCG version 7.B (Genetics
Computer Group, Madison, WI).
2.2. Functional expression of rabbit LAT2 cDNA
The vaccinia virus expression system was used to
functionally characterize the cloned cDNA as de-
scribed previously [17^19]. The cDNAs of rabbit
LAT2, human 4F2hc and human rBAT were all
cloned into pSPORT such that the sense transcrip-
tion of the cDNAs is under the control of T7 pro-
moter. The cDNAs were transfected into HRPE cells
grown in 24-well tissue culture plates using lipofectin
and the functional expression of the cDNA was an-
alyzed 12 h later by measuring radiolabeled amino
acid uptake. One microgram of the plasmid carrying
the speci¢c cDNA (LAT2, 4F2hc or rBAT) was used
per well. Sister wells transfected identically with vec-
tor alone served as control. The DNA:lipofectin ra-
tio was kept constant at 1:2.5 in all cases by includ-
ing the empty vector DNA wherever necessary. The
transport bu¡er was composed of 25 mM HEPES/
Tris (pH 7.5), supplemented with 140 mM NaCl, 5.4
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mM KCl, 1.8 mM CaCl2, 0.8 mM MgSO4, and 5 mM
glucose. When the e¡ect of Na on amino acid up-
take was studied, the NaCl in the bu¡er was replaced
with N-methyl-D-glucamine (NMDG) chloride. The
pH of the transport bu¡er was varied by adjusting
the concentrations of HEPES, MES, and Tris appro-
priately. Uptake was initiated by incubating the cell
monolayers with radiolabeled amino acids in trans-
port bu¡er for a suitable time period. Following the
incubation, the medium containing the radiolabeled
substrate was aspirated o¡ and the cells were washed
with 2U2 ml of ice-cold transport bu¡er. The cells
were then solubilized in 0.5% SDS in 0.2 N NaOH,
transferred to vials and radioactivity associated with
the cells quantitated by liquid scintillation spectrom-
etry. Initial experiments revealed that the cDNA-spe-
ci¢c transport was linear at least up to 20 min. All
subsequent experiments were therefore carried out
using a 15-min incubation period. The experiments
were repeated 2^3 times with independent transfec-
tions, each done in duplicate or triplicate. Data are
presented as means þ S.E. of these replicate measure-
ments.
2.3. Northern blot analysis
Poly(A) RNA, isolated from di¡erent rabbit tis-
sues (small intestine, kidney, heart, lung, liver, and
skeletal muscle), was used for Northern blot analysis.
The membrane ¢lter containing the size-fractionated
RNA was probed sequentially, ¢rst with LAT2
cDNA and then, following stripping, with cyclophil-
lin cDNA. Both probes were labeled with
[K-32P]dCTP by random priming using the Ready-
to-go oligolabeling kit. The hybridization and post-
hybridization washings were done under high strin-
gency conditions.
3. Results and discussion
3.1. Structural features of rabbit LAT2
The rabbit LAT2 cDNA (Genbank accession no.
AF170106) is 4070 bp long with an open reading
frame of 1608 bp (including the termination codon),
encoding a protein of 535 amino acids (Fig. 1). The
open reading frame is £anked by a 5P non-coding
sequence of 743 bp long and a 3P non-coding se-
quence of 1719 bp long. The predicted molecular
mass of the protein is 58 kDa. Hydrophobicity anal-
ysis of the predicted amino acid sequence using the
algorithm of Kyle and Doolittle [22] with a window
size of 17^23 amino acid residues indicates that rab-
bit LAT2 contains 12 putative transmembrane do-
mains. Base on the inside-positive rule of membrane
topology of integral membrane proteins, both the
amino terminus and the carboxy terminus lie on
the cytoplasmic side. The protein does not contain
any N-linked glycosylation sites in putative extracel-
lular domains. It does possess, however, one site for
protein kinase A-dependent phosphorylation (Thr-
363), three sites for protein kinase C-dependent
phosphorylation (Thr-11, Thr-337, and Thr-487),
and one site for tyrosine kinase-dependent phosphor-
ylation (Tyr-109) in putative intracellular domains.
Blast search indicates that rabbit LAT2 is most closely
related to human LAT1 in amino acid sequence (52%
identity). The sequence comparison between rabbit
LAT2 and human LAT1 is given in Fig. 1.
3.2. Functional characteristics of rabbit LAT2
Since the newly cloned transporter bears structural
similarity to LAT1 that functions as a heterodimer
with 4F2hc to induce system L-like amino acid trans-
port activity, we investigated the ability of LAT2 to
mediate amino acid transport with or without the co-
expression of 4F2hc in the human retinal pigment
epithelial (HRPE) cell line. Several amino acids
were initially tested as possible substrates. These
studies showed that the 4F2hc/LAT2 complex medi-
ated the transport of several neutral amino acids
(glutamine, serine, alanine, threonine, leucine, isoleu-
cine, phenylalanine, and tryptophan), but not of
anionic amino acids and cationic amino acids (data
not shown). Fig. 2 describes the characteristics of the
transport of glutamine as a representative of the
transportable neutral amino acids. In the presence
of Na, neither 4F2hc nor LAT2 mediated glutamine
transport (Fig. 2A). Similarly, the transport activity
remained unaltered, even when the two proteins were
co-expressed. However, when measured in the ab-
sence of Na, the transport of glutamine was much
higher in cells co-expressing the two proteins than in
cells expressing either of the proteins independently
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(Fig. 2B). These data show that the 4F2hc/LAT2
complex mediates Na-independent transport of glu-
tamine. It is of some interest that the complex-medi-
ated glutamine transport could not be detected when
measured in the presence of Na. A Na-indepen-
dent transport process is expected to be detectable
both in the presence and absence of Na. It is pos-
sible that the high endogenous glutamine transport
activity seen in the presence of Na masks the
4F2hc/LAT2 complex-mediated transport activity in
this experimental system. Since 4F2hc is structurally
related to rBAT [5], we then examined if LAT2 is
capable of interacting with rBAT to induce the
Na-independent glutamine transport activity. In
the presence as well as absence of Na, rBAT and
LAT2 failed to induce glutamine transport either in-
dependently or together (Fig. 2C,D).
Since the transport activity of the 4F2hc/LAT2
complex was much higher for glutamine and serine
than for other neutral amino acids, we examined the
interaction of these two substrates with the 4F2hc/
LAT2 complex in detail. Fig. 3 describes the satura-
tion kinetics of Na-independent transport of gluta-
mine (Fig. 3A) and serine (Fig. 3C) in control cells
transfected with vector alone or in cells co-expressing
4F2hc and LAT2. The transport was saturable in
each case. Fig. 3B and D describe the saturation
kinetics of the 4F2hc/LAT2 complex-speci¢c trans-
port of glutamine and serine. The Michaelis^Menten
constant (Kt) for the 4F2hc/LAT2 complex-mediated
transport was 316 þ 67 WM for glutamine and
204 þ 17 WM for serine.
Fig. 4 describes the speci¢city of the transport
process mediated by the 4F2hc/LAT2 complex as
Fig. 1. Primary structure of rabbit LAT2. The sequence of rabbit LAT2 is compared with that of human LAT1. The putative trans-
membrane domains in rabbit LAT2 are underlined.
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evidenced from the ability of various unlabeled ami-
no acids to compete with radiolabeled glutamine and
serine for the transport process. Only the 4F2hc/
LAT2 complex-speci¢c transport was analyzed. The
transport of [3H]glutamine (1 WM) was markedly in-
hibited by 5 mM unlabeled glutamine, leucine, ala-
nine, serine, cysteine, phenylalanine, tryptophan,
threonine, and the system L-speci¢c amino acid
BCH. In contrast, the anionic amino acids glutamate
and aspartate, the cationic amino acids arginine and
lysine, and the imino acid proline did not compete
with [3H]glutamine. Similarly, cystine also failed to
inhibit [3H]glutamine transport. The inhibition pat-
tern of [3H]serine transport was exactly the same as
that of [3H]glutamine transport. This substrate spe-
ci¢city is the characteristic of system L. The inability
to interact with cationic amino acids eliminates the
possible identity of the 4F2hc/LAT2 complex-medi-
ated transport process with systems y L and b0;.
The dose^response relationship for the inhibition of
the 4F2hc/LAT2 complex-mediated transport of
[3H]glutamine by seven di¡erent neutral amino acids
is given in Fig. 5. The IC50 values (i.e. concentration
of unlabeled amino acid at which the inhibition was
50%) for these amino acids were as follows: threo-
nine, 79 þ 5 WM; phenylalanine, 181 þ 23 WM; tryp-
tophan, 296 þ 17 WM; serine, 306 þ 16 WM; gluta-
mine, 318 þ 38 WM; leucine, 324 þ 7 WM; alanine,
791 þ 106 WM. The IC50 values for glutamine and
serine to inhibit [3H]glutamine transport (318 þ 38
WM and 306 þ 16 WM, respectively) agreed closely
with the corresponding Kt values calculated directly
Fig. 2. Characteristics of glutamine transport associated with LAT2. HRPE cells were transfected with pSPORT vector, human 4F2hc
cDNA, human rBAT cDNA, and rabbit LAT2 cDNA either independently or together. Transport of 1 WM [3H]glutamine was mea-
sured in these cells with a 15-min incubation in the presence (A,C) or absence (B,D) of Na.
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from the transport of these two amino acids
(316 þ 67 WM and 204 þ 17 WM, respectively).
The functional characteristics of LAT1 cloned
from rat and human tissues have been studied in
detail [15,17]. Comparison of the characteristics of
LAT1 with those of LAT2 reveals important di¡er-
ences in substrate selectivity and a⁄nity. LAT1 in-
teracts preferentially with large neutral amino acids.
Short chain neutral amino acids show comparatively
less a⁄nity for LAT1. In contrast, LAT2 has a much
broader substrate selectivity, interacting with short
chain as well as large neutral amino acids with com-
parable a⁄nity. In terms of substrate a⁄nity, LAT1
is a high-a⁄nity transporter with Kt values for trans-
portable substrates, such as tryptophan, in the range
of 10^20 WM. In contrast, LAT2 is a relatively low-
a⁄nity transporter with Kt values for transportable
substrates being several-fold higher than observed in
the case of LAT1.
A unique characteristic of LAT1 is its ability to
interact with D-amino acids [15]. D-Isomers of leu-
cine, phenylalanine, and methionine are recognized
as substrates by LAT1, even though D-isomers of
valine, histidine, tyrosine, and tryptophan are not.
Since the present study has already revealed signi¢-
cant di¡erences between LAT1 and LAT2 in terms
of substrate selectivity and a⁄nity, we compared the
interaction of these two transporters with D-leucine
and D-valine. Human LAT1 and rabbit LAT2 were
co-expressed with human 4F2hc and the activities of
Fig. 3. Saturation kinetics of glutamine transport (A) and serine transport (C), measured in the absence of Na, in cells transfected
with vector alone (a) and in cells co-expressing 4F2hc and LAT2 (b). Saturation kinetics of glutamine transport (B) and serine trans-
port (D) speci¢c for the 4F2hc/LAT2 complex, given either as substrate concentration versus transport or as an Eadie^Hofstee plot
(inset).
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the 4F2hc/LAT1 and 4F2hc/LAT2 complexes were
measured with [3H]tryptophan and [3H]serine as ap-
propriate substrates, respectively. The ability of D-
leucine and D-valine to inhibit these transport activ-
ities was compared (Fig. 6A). As observed earlier
[15], the LAT1-associated [3H]tryptophan transport
was inhibited markedly by D-leucine (IC50, 34 þ 4
WM). D-valine was about 200-fold less potent (IC50,
7.0 þ 1.1 mM). The LAT2-associated [3H]serine
transport was also inhibited by D-leucine, but with
an IC50 value of s 10 mM. D-valine was almost to-
tally ine¡ective. Thus, the a⁄nity of D-leucine for
LAT2 appears to be at least 300-fold lower than
for LAT1. Thus, LAT2 di¡ers from LAT1 in its
interaction with D-leucine.
We also analyzed the pH-dependence of LAT2 in
the present study because our earlier work [17] has
shown that LAT1 activity is not in£uenced by pH in
the range of 5.5^8.5. The present studies show that
the transport activity of LAT2 is signi¢cantly in£u-
enced by pH in this range (Fig. 6B). The activity is
much higher at pH 6.5 than at pH 8.5. With gluta-
mine as the substrate, the activity increases almost
100% when the pH is changed from 8.5 to 6.5. The
corresponding increase is about 70% with serine as
the substrate. The di¡erence between the transport
activities at pH 8.5 and 6.5 is statistically signi¢cant
in both cases (P6 0.05). We have shown earlier that
system L transport activity in human placental cho-
riocarcinoma cells is stimulated by acidic pH [23,24],
Fig. 4. Amino acid inhibition pro¢le of [3H]glutamine transport
(A) and [3H]serine transport (B) mediated by the 4F2hc/LAT2
complex. Transport of [3H]glutamine (1 WM) and [3H]serine (1
WM) was measured with a 15-min incubation in the absence of
Na in cells transfected with vector alone and in cells co-ex-
pressing 4F2hc and LAT2 in the presence or absence of indi-
cated amino acids (5 mM). Transport in vector-transfected cells
was subtracted from corresponding transport in cells co-express-
ing 4F2hc and LAT2 to calculate the 4F2hc/LAT2 complex-
speci¢c transport. Results are given as percent of control trans-
port measured in the absence of inhibitory amino acids.
Fig. 5. Inhibition of the 4F2hc/LAT2 complex-speci¢c
[3H]glutamine transport by alanine (a), leucine (b), glutamine
(E), tryptophan (O), phenylalanine (R), threonine (7), and
serine (8). Transport of 1 WM [3H]glutamine was measured
with a 15-min incubation in the absence of Na in cells trans-
fected with vector alone and in cells co-expressing 4F2hc and
LAT2 in the presence of varying concentrations of unlabeled
amino acids. Transport in vector-transfected cells was sub-
tracted from corresponding transport in cells co-expressing
4F2hc and LAT2 to calculate the 4F2hc/LAT2 complex-speci¢c
transport. Results are given as percent of control transport
measured in the absence of inhibitory amino acids.
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suggesting that the pH-responsive transport in these
cells is likely to be mediated by LAT2. Thus, pH-
dependence is an additional distinguishing character-
istic between LAT1 and LAT2.
3.3. Expression pattern of LAT2 in rabbit tissues
The tissue distribution pattern of LAT2 was
studied by Northern blot analysis (Fig. 7). In the
rabbit, the LAT2-speci¢c transcripts (4.4 kb in size)
was detectable only in the small intestine and kidney.
Heart, skeletal muscle, liver, and lung were negative.
The tissue distribution pattern of LAT2 is clearly
di¡erent from that of LAT1 which is expressed in
most tissues except small intestine [15,17].
In summary, we have cloned and functionally
characterized a new amino acid transport-associated
protein which interacts with 4F2hc to induce system
Fig. 6. (A) Comparison of the interaction of the 4F2hc/LAT2
complex and the 4F2hc/LAT1 complex with D-amino acids.
Cells were transfected with vector alone, human 4F2hc cDNA
plus rabbit LAT2 cDNA or human 4F2hc cDNA plus human
LAT1 cDNA. Transport was measured with a 15-min incuba-
tion in the absence of Na. Transport of 1 WM [3H]serine was
measured to assess LAT2-associated activity (E,F) while trans-
port of 1 WM [3H]tryptophan was measured to assess LAT1-as-
sociated activity (a,b). In both cases, transport measured in
vector-transfected cells was subtracted from corresponding
transport measured in cells co-expressing 4F2hc/LAT2 or
4F2hc/LAT1 to calculate the transport speci¢c for the 4F2hc/
LAT2 complex (E,F) or for the 4F2hc/LAT1 complex, (a,b).
Transport was measured in the presence of varying concentra-
tions of D-leucine (a,E) or D-valine (b,F). Results are given as
percent of control transport measured in the absence of inhibi-
tory amino acids. (B) pH-Dependence of 4F2hc/LAT2-speci¢c
transport of glutamine (a) and serine (b). Transport of 1 WM
[3H]glutamine and 1 WM [3H]serine was measured at di¡erent
pH with a-15 min incubation in the absence of Na in cells
transfected with vector alone and in cells co-expressing human
4F2hc and rabbit LAT2. Data represent only the 4F2hc/LAT2
complex-speci¢c transport calculated by subtracting the trans-
port in vector-transfected cells from the corresponding transport
in cells expressing the 4F2hc/LAT2 complex.
Fig. 7. Northern blot analysis of LAT2 mRNA expression in
rabbit tissues. The blot was hybridized sequentially with 32P-la-
beled rabbit LAT2 cDNA and cyclophillin cDNA. Each lane
contained 5 Wg of poly(A) RNA isolated from the tissues indi-
cated.
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L-like transport activity. This protein, called LAT2,
is distinct from the previously described LAT1. Even
though both LAT1 and LAT2 interact with 4F2hc to
induce system L-like amino acid transport activity,
the two systems di¡er signi¢cantly in substrate selec-
tivity, substrate a⁄nity, interaction with D-leucine,
pH-dependence and tissue distribution. While this
manuscript was in preparation, Segawa et al. [25]
and Pineda et al. [26] reported the cloning and func-
tional characterization of the rat and human homo-
logs of rabbit LAT2.
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